InvestorsHub Logo

DewDiligence

10/16/19 11:33 AM

#226426 RE: DewDiligence #218965

LLY announces phase-3 failure of cancer drug from $1.6B ARMO buyout (#msg-140678701):

https://finance.yahoo.com/news/lilly-announces-phase-3-study-104500042.html